MRK logo

Merck & Co (MRK) Selling, General & Administrative Expenses

Annual SG&A

$10.50 B
+$462.00 M+4.60%

31 December 2023

MRK Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$2.73 B
-$8.00 M-0.29%

30 September 2024

MRK Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

$232.16 B
+$4.30 B+1.89%

30 September 2024

MRK TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRK Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.6%+8.4%+2135.1%
3 y3 years+17.3%+16.9%+2363.8%
5 y5 years+4.0%+5.5%+2139.0%

MRK Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+17.3%-3.5%+17.6%-3.9%+18.0%
5 y5 yearsat high+17.3%-3.5%+58.0%-3.9%+30.6%
alltimeall time-23.5%+749.2%-26.3%+434.9%-3.9%+8573.8%

Merck & Co Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$2.73 B(-0.3%)
$10.76 B(+2.0%)
June 2024
-
$2.74 B(+10.3%)
$10.54 B(+0.4%)
Mar 2024
-
$2.48 B(-11.4%)
$10.51 B(+0.0%)
Dec 2023
$10.50 B(+4.6%)
$2.80 B(+11.3%)
$10.50 B(+1.1%)
Sept 2023
-
$2.52 B(-6.8%)
$10.39 B(-0.0%)
June 2023
-
$2.70 B(+9.0%)
$10.39 B(+1.9%)
Mar 2023
-
$2.48 B(-7.7%)
$10.20 B(+1.6%)
Dec 2022
$10.04 B(+4.2%)
$2.69 B(+6.6%)
$10.04 B(-1.4%)
Sept 2022
-
$2.52 B(+0.3%)
$10.19 B(+1.8%)
June 2022
-
$2.51 B(+8.1%)
$10.00 B(+2.4%)
Mar 2022
-
$2.32 B(-17.9%)
$9.77 B(+1.4%)
Dec 2021
$9.63 B(+7.6%)
$2.83 B(+21.1%)
$9.63 B(+2.2%)
Sept 2021
-
$2.34 B(+2.4%)
$9.42 B(+3.0%)
June 2021
-
$2.28 B(+4.3%)
$9.15 B(+2.2%)
Mar 2021
-
$2.19 B(-16.5%)
$8.95 B(-3.9%)
Dec 2020
$8.96 B(-5.3%)
$2.62 B(+27.1%)
$9.32 B(+10.6%)
Sept 2020
-
$2.06 B(-1.2%)
$8.43 B(-5.9%)
June 2020
-
$2.08 B(-18.4%)
$8.96 B(-6.5%)
Mar 2020
-
$2.56 B(+47.8%)
$9.59 B(+1.4%)
Dec 2019
$9.46 B(-6.4%)
$1.73 B(-33.2%)
$9.46 B(-8.8%)
Sept 2019
-
$2.59 B(-4.5%)
$10.37 B(+1.4%)
June 2019
-
$2.71 B(+11.8%)
$10.22 B(+2.0%)
Mar 2019
-
$2.42 B(-8.2%)
$10.02 B(-0.8%)
Dec 2018
$10.10 B(+0.3%)
$2.64 B(+8.2%)
$10.10 B(+0.0%)
Sept 2018
-
$2.44 B(-2.6%)
$10.10 B(-0.2%)
June 2018
-
$2.51 B(0.0%)
$10.12 B(+0.1%)
Mar 2018
-
$2.51 B(-5.1%)
$10.11 B(+0.4%)
Dec 2017
$10.07 B(+0.6%)
$2.64 B(+7.4%)
$10.07 B(-2.0%)
Sept 2017
-
$2.46 B(-1.6%)
$10.28 B(+0.6%)
June 2017
-
$2.50 B(+1.1%)
$10.21 B(+0.4%)
Mar 2017
-
$2.47 B(-13.2%)
$10.17 B(+1.5%)
Dec 2016
$10.02 B(-2.9%)
$2.85 B(+19.0%)
$10.02 B(+2.4%)
Sept 2016
-
$2.39 B(-2.6%)
$9.78 B(-0.8%)
June 2016
-
$2.46 B(+6.0%)
$9.86 B(-1.7%)
Mar 2016
-
$2.32 B(-11.4%)
$10.03 B(-2.7%)
Dec 2015
$10.31 B(-11.1%)
$2.62 B(+5.8%)
$10.31 B(-2.9%)
Sept 2015
-
$2.47 B(-5.8%)
$10.62 B(-4.5%)
June 2015
-
$2.62 B(+0.9%)
$11.13 B(-3.0%)
Mar 2015
-
$2.60 B(-11.1%)
$11.47 B(-1.1%)
Dec 2014
$11.61 B(-2.6%)
$2.92 B(-1.7%)
$11.61 B(-0.5%)
Sept 2014
-
$2.98 B(+0.1%)
$11.66 B(+1.5%)
June 2014
-
$2.97 B(+8.7%)
$11.49 B(-1.4%)
Mar 2014
-
$2.73 B(-8.3%)
$11.66 B(-2.1%)
Dec 2013
$11.91 B(-6.8%)
$2.98 B(+6.4%)
$11.91 B(-3.3%)
Sept 2013
-
$2.80 B(-10.7%)
$12.32 B(-2.1%)
June 2013
-
$3.14 B(+5.1%)
$12.58 B(-0.9%)
Mar 2013
-
$2.99 B(-11.9%)
$12.69 B(-0.7%)
Dec 2012
$12.78 B(-7.0%)
$3.39 B(+10.7%)
$12.78 B(-2.4%)
Sept 2012
-
$3.06 B(-5.7%)
$13.09 B(-2.1%)
June 2012
-
$3.25 B(+5.7%)
$13.37 B(-2.0%)
Mar 2012
-
$3.07 B(-17.0%)
$13.64 B(-0.7%)
Dec 2011
$13.73 B(+4.6%)
$3.70 B(+10.9%)
$13.73 B(+1.2%)
Sept 2011
-
$3.34 B(-5.2%)
$13.56 B(+1.1%)
June 2011
-
$3.52 B(+11.4%)
$13.42 B(+2.7%)
Mar 2011
-
$3.16 B(-10.5%)
$13.07 B(-0.4%)
Dec 2010
$13.13 B(+53.6%)
$3.54 B(+10.8%)
$13.13 B(+0.6%)
Sept 2010
-
$3.19 B(+0.5%)
$13.04 B(+12.7%)
June 2010
-
$3.17 B(-1.5%)
$11.58 B(+14.3%)
Mar 2010
-
$3.22 B(-6.7%)
$10.13 B(+18.6%)
Dec 2009
$8.54 B(+15.8%)
$3.46 B(+100.2%)
$8.54 B(+22.9%)
Sept 2009
-
$1.73 B(-0.2%)
$6.95 B(-0.1%)
June 2009
-
$1.73 B(+5.9%)
$6.95 B(-2.8%)
Mar 2009
-
$1.63 B(-12.3%)
$7.16 B(-3.0%)
Dec 2008
$7.38 B(-2.4%)
$1.86 B(+7.6%)
$7.38 B(+2.0%)
Sept 2008
-
$1.73 B(-10.4%)
$7.23 B(-3.0%)
June 2008
-
$1.93 B(+4.1%)
$7.46 B(-2.0%)
Mar 2008
-
$1.85 B(+7.8%)
$7.61 B(+0.7%)
Dec 2007
$7.56 B(-7.5%)
$1.72 B(-11.9%)
$7.56 B(-7.7%)
Sept 2007
-
$1.95 B(-6.3%)
$8.18 B(-4.9%)
June 2007
-
$2.08 B(+15.6%)
$8.60 B(+4.2%)
Mar 2007
-
$1.80 B(-23.2%)
$8.25 B(+1.1%)
Dec 2006
$8.17 B
$2.35 B(-1.0%)
$8.17 B(+3.8%)
Sept 2006
-
$2.37 B(+36.7%)
$7.87 B(+8.7%)
DateAnnualQuarterlyTTM
June 2006
-
$1.73 B(+1.1%)
$7.24 B(-0.3%)
Mar 2006
-
$1.72 B(-16.2%)
$7.26 B(+1.5%)
Dec 2005
$7.16 B(-1.1%)
$2.05 B(+17.5%)
$7.15 B(-2.9%)
Sept 2005
-
$1.74 B(-0.8%)
$7.36 B(-0.2%)
June 2005
-
$1.76 B(+9.3%)
$7.37 B(+1.9%)
Mar 2005
-
$1.61 B(-28.9%)
$7.23 B(-0.1%)
Dec 2004
$7.24 B(+16.7%)
$2.26 B(+28.8%)
$7.24 B(+9.5%)
Sept 2004
-
$1.75 B(+8.5%)
$6.61 B(+4.6%)
June 2004
-
$1.62 B(+0.3%)
$6.32 B(+0.4%)
Mar 2004
-
$1.61 B(-1.3%)
$6.30 B(+1.6%)
Dec 2003
$6.20 B(+9.7%)
$1.63 B(+11.6%)
$6.20 B(+1.5%)
Sept 2003
-
$1.46 B(-7.9%)
$6.11 B(+0.9%)
June 2003
-
$1.59 B(+5.0%)
$6.05 B(+1.9%)
Mar 2003
-
$1.51 B(-1.6%)
$5.94 B(+0.8%)
Dec 2002
$5.65 B(-0.8%)
$1.54 B(+9.3%)
$5.89 B(+9.4%)
Sept 2002
-
$1.41 B(-4.8%)
$5.38 B(-2.1%)
June 2002
-
$1.48 B(+0.9%)
$5.50 B(-2.8%)
Mar 2002
-
$1.46 B(+42.0%)
$5.66 B(-0.7%)
Dec 2001
$5.70 B(-7.6%)
$1.03 B(-32.4%)
$5.70 B(-11.5%)
Sept 2001
-
$1.53 B(-6.8%)
$6.44 B(+0.2%)
June 2001
-
$1.64 B(+8.7%)
$6.43 B(+2.8%)
Mar 2001
-
$1.51 B(-15.1%)
$6.26 B(+1.4%)
Dec 2000
$6.17 B(+18.6%)
$1.77 B(+17.3%)
$6.17 B(+3.1%)
Sept 2000
-
$1.51 B(+3.4%)
$5.98 B(+4.2%)
June 2000
-
$1.46 B(+3.3%)
$5.74 B(+5.1%)
Mar 2000
-
$1.42 B(-10.8%)
$5.46 B(+5.1%)
Dec 1999
$5.20 B(+15.3%)
$1.59 B(+24.8%)
$5.20 B(+4.4%)
Sept 1999
-
$1.27 B(+7.5%)
$4.98 B(+3.9%)
June 1999
-
$1.18 B(+2.6%)
$4.80 B(+2.7%)
Mar 1999
-
$1.15 B(-15.8%)
$4.67 B(+3.5%)
Dec 1998
$4.51 B(+4.9%)
$1.37 B(+26.0%)
$4.51 B(+5.2%)
Sept 1998
-
$1.09 B(+2.7%)
$4.29 B(+0.9%)
June 1998
-
$1.06 B(+6.4%)
$4.25 B(+0.3%)
Mar 1998
-
$995.10 M(-13.2%)
$4.23 B(-1.5%)
Dec 1997
$4.30 B(+11.9%)
$1.15 B(+9.3%)
$4.30 B(+0.2%)
Sept 1997
-
$1.05 B(+0.4%)
$4.29 B(+2.5%)
June 1997
-
$1.04 B(-1.6%)
$4.19 B(+2.4%)
Mar 1997
-
$1.06 B(-6.9%)
$4.09 B(+6.4%)
Dec 1996
$3.84 B(+16.5%)
$1.14 B(+20.9%)
$3.84 B(+6.3%)
Sept 1996
-
$941.80 M(-0.5%)
$3.61 B(+5.1%)
June 1996
-
$946.20 M(+16.2%)
$3.44 B(+2.9%)
Mar 1996
-
$814.30 M(-10.6%)
$3.34 B(+1.3%)
Dec 1995
$3.30 B(+3.8%)
$911.00 M(+18.7%)
$3.30 B(+1.1%)
Sept 1995
-
$767.20 M(-9.7%)
$3.26 B(-1.6%)
June 1995
-
$849.60 M(+10.3%)
$3.31 B(+3.9%)
Mar 1995
-
$770.00 M(-11.9%)
$3.19 B(+0.4%)
Dec 1994
$3.18 B(+9.0%)
$874.20 M(+6.5%)
$3.18 B(+113.6%)
Sept 1994
-
$820.70 M(+12.9%)
$1.49 B(-10.7%)
June 1994
-
$726.70 M(-3.9%)
$1.67 B(-38.7%)
Mar 1994
-
$755.90 M(-192.7%)
$2.72 B(-6.8%)
Dec 1993
$2.91 B(-28.5%)
-$815.50 M(-181.6%)
$2.91 B(-40.6%)
Sept 1993
-
$999.10 M(-43.8%)
$4.91 B(-1.1%)
June 1993
-
$1.78 B(+86.6%)
$4.97 B(+21.0%)
Mar 1993
-
$952.60 M(-19.2%)
$4.10 B(+0.7%)
Dec 1992
$4.07 B(+14.5%)
$1.18 B(+11.7%)
$4.07 B(+4.2%)
Sept 1992
-
$1.06 B(+15.4%)
$3.91 B(+5.8%)
June 1992
-
$915.20 M(-1.0%)
$3.69 B(+2.2%)
Mar 1992
-
$924.70 M(-8.8%)
$3.62 B(+1.6%)
Dec 1991
$3.56 B(+9.8%)
$1.01 B(+20.6%)
$3.56 B(+2.2%)
Sept 1991
-
$840.80 M(+0.6%)
$3.48 B(+1.3%)
June 1991
-
$836.00 M(-3.6%)
$3.44 B(+2.2%)
Mar 1991
-
$867.30 M(-7.3%)
$3.36 B(+3.7%)
Dec 1990
$3.24 B(+17.3%)
$936.00 M(+17.4%)
$3.24 B(+4.3%)
Sept 1990
-
$797.20 M(+4.6%)
$3.11 B(+4.7%)
June 1990
-
$761.90 M(+2.0%)
$2.97 B(+34.5%)
Mar 1990
-
$746.80 M(-6.9%)
$2.21 B(+51.2%)
Dec 1989
$2.76 B(+8.5%)
$801.90 M(+22.0%)
$1.46 B(+122.0%)
Sept 1989
-
$657.40 M
$657.40 M
Dec 1988
$2.55 B(+13.3%)
-
-
Dec 1987
$2.25 B(+28.5%)
-
-
Dec 1986
$1.75 B(+31.5%)
-
-
Dec 1985
$1.33 B(+7.6%)
-
-
Dec 1984
$1.24 B
-
-

FAQ

  • What is Merck & Co annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Merck & Co?
  • What is Merck & Co annual SG&A year-on-year change?
  • What is Merck & Co quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Merck & Co?
  • What is Merck & Co quarterly SG&A year-on-year change?
  • What is Merck & Co TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Merck & Co?
  • What is Merck & Co TTM SG&A year-on-year change?

What is Merck & Co annual selling, general & administrative expenses?

The current annual SG&A of MRK is $10.50 B

What is the all time high annual SG&A for Merck & Co?

Merck & Co all-time high annual selling, general & administrative expenses is $13.73 B

What is Merck & Co annual SG&A year-on-year change?

Over the past year, MRK annual selling, general & administrative expenses has changed by +$462.00 M (+4.60%)

What is Merck & Co quarterly selling, general & administrative expenses?

The current quarterly SG&A of MRK is $2.73 B

What is the all time high quarterly SG&A for Merck & Co?

Merck & Co all-time high quarterly selling, general & administrative expenses is $3.70 B

What is Merck & Co quarterly SG&A year-on-year change?

Over the past year, MRK quarterly selling, general & administrative expenses has changed by +$212.00 M (+8.42%)

What is Merck & Co TTM selling, general & administrative expenses?

The current TTM SG&A of MRK is $232.16 B

What is the all time high TTM SG&A for Merck & Co?

Merck & Co all-time high TTM selling, general & administrative expenses is $13.73 B

What is Merck & Co TTM SG&A year-on-year change?

Over the past year, MRK TTM selling, general & administrative expenses has changed by +$221.78 B (+2135.13%)